IFN-γ and IgA against non-methylated heparin-binding hemagglutinin as markers of protective immunity and latent tuberculosis: Results of a longitudinal study from an endemic setting

Journal of Infection

Volumn 72, Issue 2, 2016, Pages 189-200

  Belay, Mulugeta ^a,b   Legesse, Mengistu ^a   Mihret, Adane ^c,d   Ottenhoff, Tom H M ^e   Franken, Kees L ^e   Bjune, Gunnar ^b   Abebe, Fekadu ^b  

^a ADDIS ABABA UNIVERSITY   (Ethiopia)

^b UNIVERSITY OF OSLO   (Norway)

^c ARMAUER HANSEN RESEARCH INSTITUTE   (Ethiopia)

^d ADDIS ABABA UNIVERSITY   (Ethiopia)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Community controls; Contacts; HBHA; IFN ; IgA; IgG; IgM; IL 10; Patients; Tuberculosis

Indexed keywords

ANTIBODY; BIOLOGICAL MARKER; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 10; MEMBRANE PROTEIN; PROTEIN HBHA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BACTERIUM ANTIBODY; HEPARIN-BINDING HEMAGGLUTININ; LECTIN; TUMOR NECROSIS FACTOR;

ADULT; ANTIBODY SPECIFICITY; ARTICLE; BLOOD ANALYSIS; CELLULAR IMMUNITY; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE RESPONSE; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LATENT TUBERCULOSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; SUPERNATANT; ADOLESCENT; BLOOD; IMMUNOLOGY; MIDDLE AGED; MONONUCLEAR CELL; MYCOBACTERIUM TUBERCULOSIS; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; BIOMARKERS; FEMALE; HUMANS; IMMUNOGLOBULIN A; INTERFERON-GAMMA; INTERLEUKIN-10; LATENT TUBERCULOSIS; LECTINS; LEUKOCYTES, MONONUCLEAR; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84960353465     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2015.09.040     Document Type: Article

References (50)

1. WHO Global tuberculosis report 2014 2014, WHO, Geneva.
2. Locht C., Hougardy J.M., Rouanet C., Place S., Mascart F. Heparin-binding hemagglutinin, from an extrapulmonary dissemination factor to a powerful diagnostic and protective antigen against tuberculosis. Tuberc (Edinburgh, Scotland) 2006 May-Jul, 86(3-4):303-309. PubMed PMID: 16510310. Epub 2006/03/03. eng.
3. Glatman-Freedman A., Casadevall A. Serum therapy for tuberculosis revisited: reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis. Clin Microbiol Rev 1998 Jul, 11(3):514-532. PubMed PMID: 9665981. Pubmed Central PMCID: Pmc88894. Epub 1998/07/17. eng.
4. Abebe F., Bjune G. The protective role of antibody responses during Mycobacterium tuberculosis infection. Clin Exp Immunol 2009 Aug, 157(2):235-243. PubMed PMID: 19604263. Pubmed Central PMCID: PMC2730849. Epub 2009/07/17. eng.
5. Achkar J.M., Casadevall A. Antibody-mediated immunity against tuberculosis: implications for vaccine development. Cell Host Microbe 2013 Mar 13, 13(3):250-262. PubMed PMID: 23498951. Pubmed Central PMCID: PMC3759397. Epub 2013/03/19. eng.
6. Glatman-Freedman A. Advances in antibody-mediated immunity against Mycobacterium tuberculosis: implications for a novel vaccine strategy. FEMS Immunol Med Microbiol 2003 Oct 24, 39(1):9-16. PubMed PMID: 14556990. Epub 2003/10/15. eng.
7. Menozzi F.D., Rouse J.H., Alavi M., Laude-Sharp M., Muller J., Bischoff R., et al. Identification of a heparin-binding hemagglutinin present in mycobacteria. J Exp Med 1996 Sep 1, 184(3):993-1001. PubMed PMID: 9064359. Pubmed Central PMCID: Pmc2192777. Epub 1996/09/01. eng.
8. Pethe K., Alonso S., Biet F., Delogu G., Brennan M.J., Locht C., et al. The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination. Nature 2001 Jul 12, 412(6843):190-194. PubMed PMID: 11449276. Epub 2001/07/13. eng.
9. Sohn H., Kim J.S., Shin S.J., Kim K., Won C.J., Kim W.S., et al. Targeting of Mycobacterium tuberculosis heparin-binding hemagglutinin to mitochondria in macrophages. PLoS Pathog 2011 Dec, 7(12):e1002435. PubMed PMID: 22174691. Pubmed Central PMCID: Pmc3234249. Epub 2011/12/17. eng.
10. Guerrero G.G., Debrie A.S., Locht C. Boosting with mycobacterial heparin-binding haemagglutinin enhances protection of Mycobacterium bovis BCG-vaccinated newborn mice against M. tuberculosis. Vaccine 2010 Jun 17, 28(27):4340-4347. PubMed PMID: 20447476. Epub 2010/05/08. eng.
11. Kohama H., Umemura M., Okamoto Y., Yahagi A., Goga H., Harakuni T., et al. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guerin (BCG) in infected mice. Vaccine 2008 Feb 13, 26(7):924-932. PubMed PMID: 18192091. Epub 2008/01/15. eng.
12. Parra M., Pickett T., Delogu G., Dheenadhayalan V., Debrie A.S., Locht C., et al. The mycobacterial heparin-binding hemagglutinin is a protective antigen in the mouse aerosol challenge model of tuberculosis. Infect Immun 2004 Dec, 72(12):6799-6805. PubMed PMID: 15557600. Pubmed Central PMCID: Pmc529156. Epub 2004/11/24. eng.
13. Rouanet C., Debrie A.S., Lecher S., Locht C. Subcutaneous boosting with heparin binding haemagglutinin increases BCG-induced protection against tuberculosis. Microbes Infect/Institut Pasteur 2009 Nov, 11(13):995-1001. PubMed PMID: 19635582. Epub 2009/07/29. eng.
14. Zhao S., Zhao Y., Mao F., Zhang C., Bai B., Zhang H., et al. Protective and therapeutic efficacy of Mycobacterium smegmatis expressing HBHA-hIL12 fusion protein against Mycobacterium tuberculosis in mice. PLoS One 2012, 7(2):e31908. PubMed PMID: 22363768. Pubmed Central PMCID: Pmc3283714. Epub 2012/03/01. eng.
15. Guerrero G.G., Locht C. Recombinant HBHA boosting effect on BCG-induced immunity against Mycobacterium tuberculosis infection. Clin Dev Immunol 2011, 2011. PubMed PMID: 21647410. Pubmed Central PMCID: Pmc3102518. Epub 2011/06/08. eng.
16. TBVI. Accelerating TB vaccine research and development through partnership. [cited 2015 October 30]. Available at: . http://www.tbvi.eu/what-we-do/pipeline-of-vaccines/.
17. Shin A.R., Lee K.S., Lee J.S., Kim S.Y., Song C.H., Jung S.B., et al. Mycobacterium tuberculosis HBHA protein reacts strongly with the serum immunoglobulin M of tuberculosis patients. Clin Vaccine Immunol: CVI 2006 Aug, 13(8):869-875. PubMed PMID: 16893986. Pubmed Central PMCID: Pmc1539112. Epub 2006/08/09. eng.
18. Hougardy J.M., Schepers K., Place S., Drowart A., Lechevin V., Verscheure V., et al. Heparin-binding-hemagglutinin-induced IFN-gamma release as a diagnostic tool for latent tuberculosis. PLoS One 2007, 2(10):e926. PubMed PMID: 17912342. Pubmed Central PMCID: Pmc1991599. Epub 2007/10/04. eng.
19. Masungi C., Temmerman S., Van Vooren J.P., Drowart A., Pethe K., Menozzi F.D., et al. Differential T and B cell responses against Mycobacterium tuberculosis heparin-binding hemagglutinin adhesin in infected healthy individuals and patients with tuberculosis. J Infect Dis 2002 Feb 15, 185(4):513-520. PubMed PMID: 11865404. Epub 2002/02/28. eng.
20. Delogu G., Chiacchio T., Vanini V., Butera O., Cuzzi G., Bua A., et al. Methylated HBHA produced in M. smegmatis discriminates between active and non-active tuberculosis disease among RD1-responders. PLoS One 2011, 6(3):e18315. PubMed PMID: 21479248. Pubmed Central PMCID: Pmc3066236. Epub 2011/04/12. eng.
21. Loxton A.G., Black G.F., Stanley K., Walzl G. Heparin-binding hemagglutinin induces IFN-gamma(+) IL-2(+) IL-17(+) multifunctional CD4(+) T cells during latent but not active tuberculosis disease. Clin Vaccine Immunol: CVI 2012 May, 19(5):746-751. PubMed PMID: 22461525. Pubmed Central PMCID: Pmc3346316. Epub 2012/03/31. eng.
22. Molicotti P., Bua A., Cubeddu M., Cannas S., Delogu G., Zanetti S. Tuberculosis patients are characterized by a low-IFN-gamma/high-TNF-alpha response to methylated HBHA produced in M. smegmatis. Diagn Microbiol Infect Dis 2011 Dec, 71(4):449-452. PubMed PMID: 22083081. Epub 2011/11/16. eng.
23. PCC Summary and statistical report of the 2007 population and housing census. Population size by age and sex 2007, CSA, Addis Ababa.
24. Belay M., Legesse M., Mihret A., Bekele Y., Ottenhoff T.H., Franken K.L., et al. Pro- and anti-inflammatory cytokines against Rv2031 are elevated during latent tuberculosis: a study in cohorts of tuberculosis patients, household contacts and community controls in an endemic setting. PLoS One 2015, 10(4):e0124134. PubMed PMID: 25897840. Epub 2015/04/22. eng.
25. Belay M., Legesse M., Dagne D., Mihret A., Bekele Y., Medhin G., et al. QuantiFERON-TB gold in-tube test conversions and reversions among tuberculosis patients and their household contacts in Addis Ababa: a one year follow-up study. BMC Infect Dis 2014 Dec 3, 14(1):654. PubMed PMID: 25466365. Pubmed Central PMCID: Pmc4264256. Epub 2014/12/04. Eng.
26. MOH Guidelines for clinical and programmatic management of TB, leprosy and TB/HIV in Ethiopia 2012, Ministry of Health, Addis Ababa.
27. MOH Guidelines for HIV counselling and testing in Ethiopia 2007, Ministry of Health, Addis Ababa.
28. Franken K.L., Hiemstra H.S., van Meijgaarden K.E., Subronto Y., den Hartigh J., Ottenhoff T.H., et al. Purification of his-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent. Protein Expr Purif 2000 Feb, 18(1):95-99. PubMed PMID: 10648174. Epub 2000/01/29. eng.
29. Commandeur S., van Meijgaarden K.E., Prins C., Pichugin A.V., Dijkman K., van den Eeden S.J., et al. An unbiased genome-wide Mycobacterium tuberculosis gene expression approach to discover antigens targeted by human T cells expressed during pulmonary infection. J Immunol (Baltimore, Md: 1950) 2013 Feb 15, 190(4):1659-1671. PubMed PMID: 23319735. Epub 2013/01/16. eng.
30. Belay M., Legesse M., Mihret A., Bekele Y., Bjune G., Abebe F. Lipoarabinomannan-specific TNF-alpha and IFN-gamma as markers of protective immunity against tuberculosis: a cohort study in an endemic setting. APMIS: acta pathologica, microbiologica, et immunologica Scandinavica 2015 Jul 22, 123(10):851-857. PubMed PMID: 26200933. Epub 2015/07/23. Eng.
31. Abebe F. Is interferon-gamma the right marker for bacille Calmette-Guerin-induced immune protection? The missing link in our understanding of tuberculosis immunology. Clin Exp Immunol 2012 Sep, 169(3):213-219. PubMed PMID: 22861360. Pubmed Central PMCID: Pmc3444997. Epub 2012/08/07. eng.
32. Alvarez N., Infante J.F., Borrero R., Mata D., Payan J.B., Hossain M.M., et al. Histopathological study of the lungs of mice receiving human secretory IgA and challenged with Mycobacterium tuberculosis. Malays J Med Sci: MJMS 2014 May, 21(3):31-37. PubMed PMID: 25246833. Pubmed Central PMCID: Pmc4163556. Epub 2014/09/24. eng.
33. Tjarnlund A., Rodriguez A., Cardona P.J., Guirado E., Ivanyi J., Singh M., et al. Polymeric IgR knockout mice are more susceptible to mycobacterial infections in the respiratory tract than wild-type mice. Int Immunol 2006 May, 18(5):807-816. PubMed PMID: 16569672. Epub 2006/03/30. eng.
34. Reljic R., Clark S.O., Williams A., Falero-Diaz G., Singh M., Challacombe S., et al. Intranasal IFNgamma extends passive IgA antibody protection of mice against Mycobacterium tuberculosis lung infection. Clin Exp Immunol 2006 Mar, 143(3):467-473. PubMed PMID: 16487246. Pubmed Central PMCID: Pmc1809609. Epub 2006/02/21. eng.
35. Balu S., Reljic R., Lewis M.J., Pleass R.J., McIntosh R., van Kooten C., et al. A novel human IgA monoclonal antibody protects against tuberculosis. J Immunol (Baltimore, Md: 1950) 2011 Mar 1, 186(5):3113-3119. PubMed PMID: 21257971. Pubmed Central PMCID: PMC3115510. Epub 2011/01/25. eng.
36. Lopez Y., Yero D., Falero-Diaz G., Olivares N., Sarmiento M.E., Sifontes S., et al. Induction of a protective response with an IgA monoclonal antibody against Mycobacterium tuberculosis 16kDa protein in a model of progressive pulmonary infection. Int J Med Microbiol: IJMM 2009 Aug, 299(6):447-452. PubMed PMID: 19157977. Epub 2009/01/23. eng.
37. Demissie A., Abebe M., Aseffa A., Rook G., Fletcher H., Zumla A., et al. Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4delta2. J Immunol (Baltimore, Md: 1950) 2004 Jun 1, 172(11):6938-6943. PubMed PMID: 15153513. Epub 2004/05/22. eng.
38. Arias-Bouda L.M., Kuijper S., Van der Werf A., Nguyen L.N., Jansen H.M., Kolk A.H. Changes in avidity and level of immunoglobulin G antibodies to Mycobacterium tuberculosis in sera of patients undergoing treatment for pulmonary tuberculosis. Clin Diagn Lab Immunol 2003 Jul, 10(4):702-709. PubMed PMID: 12853408. Pubmed Central PMCID: Pmc164257. Epub 2003/07/11. eng.
39. Mutapi F., Ndhlovu P.D., Hagan P., Spicer J.T., Mduluza T., Turner C.M., et al. Chemotherapy accelerates the development of acquired immune responses to Schistosoma haematobium infection. J Infect Dis 1998 Jul, 178(1):289-293. PubMed PMID: 9652458. Epub 1998/07/04. eng.
40. Temmerman S., Pethe K., Parra M., Alonso S., Rouanet C., Pickett T., et al. Methylation-dependent T cell immunity to Mycobacterium tuberculosis heparin-binding hemagglutinin. Nat Med 2004 Sep, 10(9):935-941. PubMed PMID: 15300244. Epub 2004/08/10. eng.
41. Stylianou E., Diogo G.R., Pepponi I., van Dolleweerd C., Arias M.A., Locht C., et al. Mucosal delivery of antigen-coated nanoparticles to lungs confers protective immunity against tuberculosis infection in mice. Eur J Immunol 2014 Feb, 44(2):440-449. PubMed PMID: 24214530. Epub 2013/11/12. eng.
42. Rahman M.J., Degano I.R., Singh M., Fernandez C. Influence of maternal gestational treatment with mycobacterial antigens on postnatal immunity in an experimental murine model. PLoS One 2010, 5(3):e9699. PubMed PMID: 20300629. Pubmed Central PMCID: Pmc2837747. Epub 2010/03/20. eng.
43. Corbiere V., Pottier G., Bonkain F., Schepers K., Verscheure V., Lecher S., et al. Risk stratification of latent tuberculosis defined by combined interferon gamma release assays. PLoS One 2012, 7(8):e43285. PubMed PMID: 22912846. Pubmed Central PMCID: Pmc3422279. Epub 2012/08/23. eng.
44. Wyndham-Thomas C., Corbiere V., Dirix V., Smits K., Domont F., Libin M., et al. Key role of effector memory CD4+ T lymphocytes in a short-incubation heparin-binding hemagglutinin gamma interferon release assay for the detection of latent tuberculosis. Clin Vaccine Immunol: CVI 2014 Mar, 21(3):321-328. PubMed PMID: 24391135. Pubmed Central PMCID: Pmc3957667. Epub 2014/01/07. eng.
45. Dessein R., Corbiere V., Nortier J., Dratwa M., Gastaldello K., Pozdzik A., et al. Heparin-binding haemagglutinin, a new tool for the detection of latent Mycobacterium tuberculosis infection in hemodialysis patients. PLoS One 2013, 8(8):e71088. PubMed PMID: 23940693. Pubmed Central PMCID: Pmc3733734. Epub 2013/08/14. eng.
46. Ringshausen F.C., Nienhaus A., Schablon A., Schlosser S., Schultze-Werninghaus G., Rohde G. Predictors of persistently positive Mycobacterium-tuberculosis-specific interferon-gamma responses in the serial testing of health care workers. BMC Infect Dis 2010, 10:220. PubMed PMID: 20653946. Pubmed Central PMCID: Pmc2916913. Epub 2010/07/27. eng.
47. Pai M., Joshi R., Dogra S., Zwerling A.A., Gajalakshmi D., Goswami K., et al. T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India. Int J Tuberc Lung Dis: Off J Int Union Against Tuberc Lung Dis 2009 Jan, 13(1):84-92. PubMed PMID: 19105884. Pubmed Central PMCID: Pmc2951989. Epub 2008/12/25. eng.
48. Kumar N.P., Gopinath V., Sridhar R., Hanna L.E., Banurekha V.V., Jawahar M.S., et al. IL-10 dependent suppression of type 1, type 2 and type 17 cytokines in active pulmonary tuberculosis. PLoS One 2013, 8(3):e59572. PubMed PMID: 23544075. Pubmed Central PMCID: Pmc3609860. Epub 2013/04/02. eng.
49. Hougardy J.M., Place S., Hildebrand M., Drowart A., Debrie A.S., Locht C., et al. Regulatory T cells depress immune responses to protective antigens in active tuberculosis. Am J Respir Crit Care Med 2007 Aug 15, 176(4):409-416. PubMed PMID: 17541018. Epub 2007/06/02. eng.
50. Wang L., Turner M.O., Elwood R.K., Schulzer M., FitzGerald J.M. A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements. Thorax 2002 Sep, 57(9):804-809. PubMed PMID: 12200526. Pubmed Central PMCID: Pmc1746436. Epub 2002/08/30. eng.